Technology transfer / Localization · Africa · Announced 10 Sept 2026

Roche → Groupe Saidal

Technology transfer / Localization deal between Roche (Switzerland) and Groupe Saidal (Algeria), covering Breast-cancer medicine, announced 10 Sept 2026. Value: Undisclosed.

Parties: Roche (Switzerland) → Groupe Saidal (Algeria)

Value
Undisclosed
Territory
Algeria
Therapeutic area
Oncology
Asset
Breast-cancer medicine(s) — specific molecule not disclosed
Announced
10 Sept 2026

Our analysis

Executive summary.

Groupe Saidal, Algeria's state pharma champion, signed a partnership contract with Roche Algérie to localize production of breast-cancer medicine(s) at Saidal's El-Harrach (Algiers) facility , built on technology transfer, know-how sharing and national-skills development.

The full analysis is free to read with a work email on this page.

Source: Algérie Eco

More deals involving Roche or Groupe Saidal

Latest deals

All Africa deals → · All technology transfer / localization deals → · Browse all emerging-market pharma deals →